BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38433576)

  • 21. Inhibition of the PIN1-NRF2/GPX4 axis imparts sensitivity to cisplatin in cervical cancer cells.
    Zhang Z; Hu Q; Ye S; Xiang L
    Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 54(9):1325-1335. PubMed ID: 35983979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers.
    Lu Z; Mao W; Yang H; Santiago-O'Farrill JM; Rask PJ; Mondal J; Chen H; Ivan C; Liu X; Liu CG; Xi Y; Masuda K; Carrami EM; Chen M; Tang Y; Pang L; Lakomy DS; Calin GA; Liang H; Ahmed AA; Vankayalapati H; Bast RC
    J Clin Invest; 2022 Jun; 132(11):. PubMed ID: 35642638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PARP inhibitors: clinical development, emerging differences, and the current therapeutic issues.
    Murthy P; Muggia F
    Cancer Drug Resist; 2019; 2(3):665-679. PubMed ID: 35582575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRCA1 and RAD51C promotor methylation in human resectable pancreatic adenocarcinoma.
    Abdallah R; Zhao S; Garinet S; Hormigos K; Le Corre D; Cros J; Perez Toralla K; Bats AS; Augustin J; Bachet JB; Taly V; Blons H; Taieb J; Laurent-Puig P
    Clin Res Hepatol Gastroenterol; 2022 May; 46(5):101880. PubMed ID: 35151910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells.
    Ye Z; Zhuo Q; Hu Q; Xu X; Mengqi Liu ; Zhang Z; Xu W; Liu W; Fan G; Qin Y; Yu X; Ji S
    Redox Biol; 2021 Jan; 38():101807. PubMed ID: 33271455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer.
    Liu M; Qin Y; Hu Q; Liu W; Ji S; Xu W; Fan G; Ye Z; Zhang Z; Xu X; Yu X; Zhuo Q
    Cancer Lett; 2021 Feb; 499():265-278. PubMed ID: 33232789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer.
    Li J; Yuan S; Norgard RJ; Yan F; Sun YH; Kim IK; Merrell AJ; Sela Y; Jiang Y; Bhanu NV; Garcia BA; Vonderheide RH; Blanco A; Stanger BZ
    Cancer Discov; 2021 Mar; 11(3):736-753. PubMed ID: 33158848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.
    Xia W; Bai H; Deng Y; Yang Y
    J Cell Mol Med; 2020 Nov; 24(21):12642-12655. PubMed ID: 32985124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olaparib for Metastatic Castration-Resistant Prostate Cancer.
    de Bono J; Mateo J; Fizazi K; Saad F; Shore N; Sandhu S; Chi KN; Sartor O; Agarwal N; Olmos D; Thiery-Vuillemin A; Twardowski P; Mehra N; Goessl C; Kang J; Burgents J; Wu W; Kohlmann A; Adelman CA; Hussain M
    N Engl J Med; 2020 May; 382(22):2091-2102. PubMed ID: 32343890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of the Prolyl Isomerase Pin1 Sensitizes BRCA1-Proficient Breast Cancer to PARP Inhibition.
    Luo ML; Zheng F; Chen W; Liang ZM; Chandramouly G; Tan J; Willis NA; Chen CH; Taveira MO; Zhou XZ; Lu KP; Scully R; Wulf GM; Hu H
    Cancer Res; 2020 Jul; 80(14):3033-3045. PubMed ID: 32193285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FGFBP1, a downstream target of the FBW7/c-Myc axis, promotes cell proliferation and migration in pancreatic cancer.
    Zhang Z; Liu M; Hu Q; Xu W; Liu W; Sun Q; Ye Z; Fan G; Xu X; Yu X; Ji S; Qin Y
    Am J Cancer Res; 2019; 9(12):2650-2664. PubMed ID: 31911852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of KLF5 is associated with poor survival and G1/S progression in pancreatic cancer.
    Li Y; Kong R; Chen H; Zhao Z; Li L; Li J; Hu J; Zhang G; Pan S; Wang Y; Wang G; Chen H; Sun B
    Aging (Albany NY); 2019 Jul; 11(14):5035-5057. PubMed ID: 31327760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maintenance Olaparib for Germline
    Golan T; Hammel P; Reni M; Van Cutsem E; Macarulla T; Hall MJ; Park JO; Hochhauser D; Arnold D; Oh DY; Reinacher-Schick A; Tortora G; Algül H; O'Reilly EM; McGuinness D; Cui KY; Schlienger K; Locker GY; Kindler HL
    N Engl J Med; 2019 Jul; 381(4):317-327. PubMed ID: 31157963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer.
    Hu Q; Qin Y; Ji S; Xu W; Liu W; Sun Q; Zhang Z; Liu M; Ni Q; Yu X; Xu X
    Cancer Lett; 2019 Jun; 452():226-236. PubMed ID: 30905812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KLF5 and MYC modulated LINC00346 contributes to gastric cancer progression through acting as a competing endogeous RNA and indicates poor outcome.
    Xu TP; Ma P; Wang WY; Shuai Y; Wang YF; Yu T; Xia R; Shu YQ
    Cell Death Differ; 2019 Nov; 26(11):2179-2193. PubMed ID: 30770877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The transcription factor Krüppel-like factor 5 promotes cell growth and metastasis via activating PI3K/AKT/Snail signaling in hepatocellular carcinoma.
    An T; Dong T; Zhou H; Chen Y; Zhang J; Zhang Y; Li Z; Yang X
    Biochem Biophys Res Commun; 2019 Jan; 508(1):159-168. PubMed ID: 30473218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Krüpple-like factor 5 is essential for mammary gland development and tumorigenesis.
    Liu R; Shi P; Zhou Z; Zhang H; Li W; Zhang H; Chen C
    J Pathol; 2018 Dec; 246(4):497-507. PubMed ID: 30101462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
    Rebbeck TR; Friebel TM; Friedman E; Hamann U; Huo D; Kwong A; Olah E; Olopade OI; Solano AR; Teo SH; Thomassen M; Weitzel JN; Chan TL; Couch FJ; Goldgar DE; Kruse TA; Palmero EI; Park SK; Torres D; van Rensburg EJ; McGuffog L; Parsons MT; Leslie G; Aalfs CM; Abugattas J; Adlard J; Agata S; Aittomäki K; Andrews L; Andrulis IL; Arason A; Arnold N; Arun BK; Asseryanis E; Auerbach L; Azzollini J; Balmaña J; Barile M; Barkardottir RB; Barrowdale D; Benitez J; Berger A; Berger R; Blanco AM; Blazer KR; Blok MJ; Bonadona V; Bonanni B; Bradbury AR; Brewer C; Buecher B; Buys SS; Caldes T; Caliebe A; Caligo MA; Campbell I; Caputo SM; Chiquette J; Chung WK; Claes KBM; Collée JM; Cook J; Davidson R; de la Hoya M; De Leeneer K; de Pauw A; Delnatte C; Diez O; Ding YC; Ditsch N; Domchek SM; Dorfling CM; Velazquez C; Dworniczak B; Eason J; Easton DF; Eeles R; Ehrencrona H; Ejlertsen B; ; Engel C; Engert S; Evans DG; Faivre L; Feliubadaló L; Ferrer SF; Foretova L; Fowler J; Frost D; Galvão HCR; Ganz PA; Garber J; Gauthier-Villars M; Gehrig A; ; Gerdes AM; Gesta P; Giannini G; Giraud S; Glendon G; Godwin AK; Greene MH; Gronwald J; Gutierrez-Barrera A; Hahnen E; Hauke J; ; Henderson A; Hentschel J; Hogervorst FBL; Honisch E; Imyanitov EN; Isaacs C; Izatt L; Izquierdo A; Jakubowska A; James P; Janavicius R; Jensen UB; John EM; Vijai J; Kaczmarek K; Karlan BY; Kast K; Investigators K; Kim SW; Konstantopoulou I; Korach J; Laitman Y; Lasa A; Lasset C; Lázaro C; Lee A; Lee MH; Lester J; Lesueur F; Liljegren A; Lindor NM; Longy M; Loud JT; Lu KH; Lubinski J; Machackova E; Manoukian S; Mari V; Martínez-Bouzas C; Matrai Z; Mebirouk N; Meijers-Heijboer HEJ; Meindl A; Mensenkamp AR; Mickys U; Miller A; Montagna M; Moysich KB; Mulligan AM; Musinsky J; Neuhausen SL; Nevanlinna H; Ngeow J; Nguyen HP; Niederacher D; Nielsen HR; Nielsen FC; Nussbaum RL; Offit K; Öfverholm A; Ong KR; Osorio A; Papi L; Papp J; Pasini B; Pedersen IS; Peixoto A; Peruga N; Peterlongo P; Pohl E; Pradhan N; Prajzendanc K; Prieur F; Pujol P; Radice P; Ramus SJ; Rantala J; Rashid MU; Rhiem K; Robson M; Rodriguez GC; Rogers MT; Rudaitis V; Schmidt AY; Schmutzler RK; Senter L; Shah PD; Sharma P; Side LE; Simard J; Singer CF; Skytte AB; Slavin TP; Snape K; Sobol H; Southey M; Steele L; Steinemann D; Sukiennicki G; Sutter C; Szabo CI; Tan YY; Teixeira MR; Terry MB; Teulé A; Thomas A; Thull DL; Tischkowitz M; Tognazzo S; Toland AE; Topka S; Trainer AH; Tung N; van Asperen CJ; van der Hout AH; van der Kolk LE; van der Luijt RB; Van Heetvelde M; Varesco L; Varon-Mateeva R; Vega A; Villarreal-Garza C; von Wachenfeldt A; Walker L; Wang-Gohrke S; Wappenschmidt B; Weber BHF; Yannoukakos D; Yoon SY; Zanzottera C; Zidan J; Zorn KK; Hutten Selkirk CG; Hulick PJ; Chenevix-Trench G; Spurdle AB; Antoniou AC; Nathanson KL
    Hum Mutat; 2018 May; 39(5):593-620. PubMed ID: 29446198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.
    He P; Yang JW; Yang VW; Bialkowska AB
    Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.